secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2026-03-10T23:59:59+00:00
Accession:  0001493152-26-009551
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharmaceuticals prices $3.5M public offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Gross proceeds of $3.5M from 2,238,800 shares and pre-funded warrants for 4,761,200 shares.
- Pre-funded warrants exercisable at $0.001 per share with 4.99% beneficial ownership limitation.
- Up to $1.5M of net proceeds allocated for marketing; remainder for working capital.
- E.F. Hutton acted as placement agent; cash fee of 4.0% of gross proceeds plus expenses.
- Offering closed March 9, 2026; registered on Form S-1 effective February 17, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226009551/0001493152-26-009551-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226009551/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-009551

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer